Barclays PLC Medicinova Inc Transaction History
Barclays PLC
- $357 Billion
- Q4 2024
A detailed history of Barclays PLC transactions in Medicinova Inc stock. As of the latest transaction made, Barclays PLC holds 95,600 shares of MNOV stock, worth $156,784. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,600
Previous 82,800
15.46%
Holding current value
$156,784
Previous $174,000
15.52%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding MNOV
# of Institutions
29Shares Held
5.13MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.81 Million0.54% of portfolio
-
Black Rock Inc. New York, NY695KShares$1.14 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA623KShares$1.02 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA515KShares$844,4580.0% of portfolio
-
Citigroup Inc502KShares$823,2090.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $80.4M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...